Codebreaker Labs Raises $4.5M to Scale Genomic AI Data
Codebreaker Labs raised $4.5M Seed led by Kickstart to generate experimental data for genomic AI models.

The big picture: Codebreaker Labs has raised $4.5 million to scale an experimental data platform designed to close the gap between identifying genetic variants and understanding their functional impact within human cells, providing crucial training data for genomic AI models.
Why it matters:
- Variant Interpretation: While genomic sequencing is routine, determining the biological significance of individual genetic variants remains a major bottleneck for clinical interpretation and biomedical research.
- AI Data Gap: Existing genomic AI models often rely on DNA sequence data or computational predictions, lacking empirical training data on what genetic changes actually do in human cells.
- Functional Evidence: Codebreaker Labs’ approach generates experimental evidence at scale, offering a new layer of information to evaluate genetic findings and improve diagnostic accuracy.
How it works:
- Experimental Platform: The company introduces individual single-nucleotide variants into disease-relevant primary human cells and measures their effects at a genome scale, evaluating tens of thousands of variants in parallel.
- Variant Atlases: These measurements create large datasets showing how specific genetic changes affect biological function, forming ‘Atlases’ that combine curated experimental data with AI models.
- AI-Powered Interpretation: The resulting information supports direct interpretation of variants and provides empirical training data for AI models, connecting computational genomic analysis with real-world cellular measurements.
The catch: While promising, Codebreaker Labs’ strategy of building foundational experimental datasets for genomic AI faces a long commercialization timeline, with the first commercial Atlas targeted for 2027. This requires sustained investment and successful execution in a competitive and rapidly evolving field where other companies are also developing computational and experimental approaches to variant interpretation and AI training data.
Key Facts
- Company: Codebreaker Labs
- Amount: $4.5M
- Round: Seed
- Investors: Kickstart (lead), Buff Gold Ventures, Children’s Hospital Colorado, Denver Ventures, Service Provider Capital, Pelican Trust
- Founder: Ryan T. Gill
- Sector: Genomic AI Data Platform
- Headquarters: Colorado, US